Troy Wadsworth, MD

Troy Wadsworth, MD, is a board-certified medical oncologist who treats a broad spectrum of oncologic and hematologic conditions including anemia and bleeding disorders. He has a special interest in treating lung, myeloma and lymphoma malignancies. He partners with patients by providing the information they need to make well-informed decisions and control the direction of their health care. Outside of work Dr. Wadsworth enjoys spending time with family, traveling and has an affinity for music.

• MultiCare Oncology Group

Schenk EL, Mandrekar SJ, Dy GK, Aubry MC, Tan AD, Dakhil SR, Sachs BA, Nieva JJ, Bertino E, Lee Hann C, Schild SE, Wadsworth TW, Adjei AA, Molina JR. A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study. J Thorac Oncol. 2020 Jan;15(1):110-119. doi: 10.1016/j.jtho.2019.09.083.